A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis.
Lim
Esther H
EH
Clinical Center, National Institutes of Health, Bethesda, Maryland, USA. ElimH@cc.nih.gov
Danthi
Narasimhan
N
Bednarski
Mark
M
Li
King C P
KC
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004337:Drug Carriers / Q000737:chemistry; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D039302:Integrin alphaVbeta3 / Q000378:metabolism*; D050997:Nanomedicine / Q000379:methods; D049329:Nanostructures / Q000737:chemistry; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000378:metabolism; D049268:Positron-Emission Tomography / Q000379:methods
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D004337:Drug Carriers; D039302:Integrin alphaVbeta3